Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization.

Chen Y, Gu H, Cheng S, Shen L, Cui F, Wang F, Yao J, Xia S, Lv H, Liang X.

Hum Vaccin Immunother. 2013 Apr;9(4):898-902. doi: 10.4161/hv.23193. Epub 2013 Jan 7.

2.

The effects of different dosage levels of hepatitis B vaccine as booster on anti-HBs-negative children 5-15 y after primary immunization; China, 2009-2010.

Chen Y, Lv H, Gu H, Cui F, Wang F, Yao J, Xia S, Liang X.

Hum Vaccin Immunother. 2014;10(2):498-504. doi: 10.4161/hv.26936. Epub 2013 Nov 5.

3.

The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.

Yao J, Ren J, Shen L, Chen Y, Liang X, Cui F, Li Q, Jiang Z, Wang F.

Hum Vaccin. 2011 Oct;7(10):1055-9. doi: 10.4161/hv.7.10.15990. Epub 2011 Oct 1.

PMID:
21989290
4.

The effects of booster vaccination on hepatitis B vaccine in anti-HBs negative infants of HBsAg-positive mothers after primary vaccination.

Gu H, Yao J, Zhu W, Lv H, Cheng S, Ling L, Xia S, Chen Y.

Hum Vaccin Immunother. 2013 Jun;9(6):1292-5. doi: 10.4161/hv.24021. Epub 2013 Feb 19.

5.

Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.

Duval B, Gîlca V, Boulianne N, Deceuninck G, Rochette L, De Serres G.

Vaccine. 2005 Jul 1;23(31):4082-7. Epub 2004 Aug 9.

PMID:
15963363
6.

[Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].

Zhao YL, Chen YG, Li J, Han GX, Tian C, Liang JL, Li G, Wang ZG, Zhu YG, Tian ZN, Zhang HY, Wan ZJ, Liang ZL, Bi SL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Jun;25(6):470-3. Chinese.

PMID:
15231119
7.

[Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].

Chlibek R, Smetana J, Bostíková V, Splino M.

Epidemiol Mikrobiol Imunol. 2011 Sep;60(3):99-108. Czech.

PMID:
22132651
8.

Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.

Zanetti AR, Romanò L, Giambi C, Pavan A, Carnelli V, Baitelli G, Malchiodi G, Valerio E, Barale A, Marchisio MA, Montù D, Tozzi AE, D'Ancona F; study group.

Lancet Infect Dis. 2010 Nov;10(11):755-61. doi: 10.1016/S1473-3099(10)70195-X. Epub 2010 Sep 29.

PMID:
20884297
9.

Antibody persistence six years after two doses of combined hepatitis A and B vaccine.

Burgess MA, McIntyre PB, Hellard M, Ruff TA, Lefevre I, Bock HL.

Vaccine. 2010 Mar 2;28(10):2222-6. doi: 10.1016/j.vaccine.2009.12.053. Epub 2010 Jan 5.

PMID:
20056187
10.

Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.

Kallinowski B, Jilg W, Buchholz L, Stremmel W, Engler S.

Z Gastroenterol. 2003 Oct;41(10):983-90.

PMID:
14562195
11.

A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines.

Giambi C, Bella A, Barale A, Montù D, Marchisio M, Oddone M, Zito S, Rapicetta M, Chionne P, Madonna E, Ciofi degli Atti ML.

BMC Infect Dis. 2008 Jul 28;8:100. doi: 10.1186/1471-2334-8-100.

12.

Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age.

van Damme P, Kafeja F, Van Der Wielen M, Leyssen M, Jacquet JM.

Pediatr Infect Dis J. 2011 Aug;30(8):703-5. doi: 10.1097/INF.0b013e3182138296.

PMID:
21346683
13.

The one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011.

Yao J, Shan H, Chen Y, Jiang ZG, Dai XW, Ren JJ, Xu KJ, Ruan B, Yang SG, Li Q.

Hum Vaccin Immunother. 2015;11(5):1114-9. doi: 10.4161/21645515.2014.987001.

14.

Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.

Shapiro AJ, Esther CR, Leigh MW, Dellon EP.

Vaccine. 2013 Jan 30;31(6):906-11. doi: 10.1016/j.vaccine.2012.12.004. Epub 2012 Dec 20.

PMID:
23261047
16.

Evaluation of immune responses to combined hepatitis A and B vaccine in HIV-infected children and children on immunosuppressive medication.

Belderok SM, Sonder GJ, van Rossum M, van Dijk-Hummelman A, Hartwig N, Scherpbier H, Geelen S, Speksnijder AG, Baaten G, van den Hoek A.

Vaccine. 2013 Aug 28;31(38):4156-63. doi: 10.1016/j.vaccine.2013.06.086. Epub 2013 Jul 8.

PMID:
23845818
17.

A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.

Li F, Hu Y, Zhou Y, Chen L, Xia W, Song Y, Tan Z, Gao L, Yang Z, Zeng G, Han X, Li J, Li J.

Pediatr Infect Dis J. 2017 May;36(5):e157-e161. doi: 10.1097/INF.0000000000001535.

PMID:
28060048
18.

Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine.

Cardell K, Akerlind B, Sällberg M, Frydén A.

J Infect Dis. 2008 Aug 1;198(3):299-304. doi: 10.1086/589722.

PMID:
18544037
19.

Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine.

Gilca V, De Serres G, Boulianne N, De Wals P, Murphy D, Trudeau G, Deceuninck G, Massé R, Duval B.

Hum Vaccin. 2010 Feb;6(2):212-8. Epub 2010 Feb 11.

PMID:
19946212
20.

[Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].

González-Huezo MS, Sánchez-Avila F, García Mayol M, Castro Narro G, Sixtos S, Lisker-Melman M, Kershenobich D.

Rev Gastroenterol Mex. 2003 Oct-Dec;68(4):271-6. Spanish.

PMID:
15125329

Supplemental Content

Support Center